These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 12820336
1. Diagnostic value of bone and tumour markers in patients with malignant diseases. Oremek GM, Weis A, Sapoutzis N, Sauer-Eppel H. Anticancer Res; 2003; 23(2A):987-90. PubMed ID: 12820336 [Abstract] [Full Text] [Related]
2. Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen. Morote J, Lorente JA, Encabo G. Cancer; 1996 Dec 01; 78(11):2374-8. PubMed ID: 8941009 [Abstract] [Full Text] [Related]
6. Biochemical markers for monitoring response to therapy: evidence for higher bone specificity by a novel marker compared with routine markers. Leeming DJ, Hegele A, Byrjalsen I, Hofmann R, Qvist P, Karsdal MA, Schrader AJ, Wagner R, Olbert P. Cancer Epidemiol Biomarkers Prev; 2008 May 01; 17(5):1269-76. PubMed ID: 18483350 [Abstract] [Full Text] [Related]
8. [Evaluation of two serum isoenzyme phosphatases as bone metastasis markers]. Desoize B, Pourny C, Amico S, Larbre H, Jardillier JC. Bull Cancer; 1990 May 01; 77(12):1211-21. PubMed ID: 2081281 [Abstract] [Full Text] [Related]
9. Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer. Kanakis I, Nikolaou M, Pectasides D, Kiamouris C, Karamanos NK. J Pharm Biomed Anal; 2004 Mar 01; 34(4):827-32. PubMed ID: 15019061 [Abstract] [Full Text] [Related]
11. Metastatic workup of patients with prostate cancer employing alkaline phosphatase and skeletal alkaline phosphatase. Wolff JM, Ittel TH, Borchers H, Boekels O, Jakse G. Anticancer Res; 1999 Mar 01; 19(4A):2653-5. PubMed ID: 10470213 [Abstract] [Full Text] [Related]
12. Biochemical markers of bone turnover in patients with localized and metastasized prostate cancer. Hegele A, Wahl HG, Varga Z, Sevinc S, Koliva L, Schrader AJ, Hofmann R, Olbert P. BJU Int; 2007 Feb 01; 99(2):330-4. PubMed ID: 17092281 [Abstract] [Full Text] [Related]
13. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer. Pollmann D, Siepmann S, Geppert R, Wernecke KD, Possinger K, Lüftner D. Anticancer Res; 2007 Feb 01; 27(4A):1853-62. PubMed ID: 17649784 [Abstract] [Full Text] [Related]
15. Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis. Koizumi M, Takahashi S, Ogata E. Anticancer Res; 2003 Feb 01; 23(5b):4095-9. PubMed ID: 14666607 [Abstract] [Full Text] [Related]
16. Procollagen type 1 amino-terminal propeptide: a marker for bone metastases in prostate carcinoma. Klepzig M, Jonas D, Oremek GM. Anticancer Res; 2009 Feb 01; 29(2):671-3. PubMed ID: 19331219 [Abstract] [Full Text] [Related]